伏邪理论与治未病思想在防治PCI术后无复流的应用探讨  

Prevention and Treatment of Fuxie Theory and Preventive Treatment of Disease in PCI No-reflow

作　　者：翟昂帅[1] 张军平[2] 郭晓辰[2] 朱亚萍[2] 许颖智[1] 

机构地区：[1]天津中医药大学,天津300193 [2]天津中医药大学第一附属医院,天津300193

出　　处：《中华中医药学刊》2012年第11期2430-2431,共2页Chinese Archives of Traditional Chinese Medicine

基　　金：国家自然科学基金资助项目(30901890)

摘　　要：经皮冠状动脉介入治疗(PCI)已成为冠心病血管重建的主要治疗手段,但术后无复流等问题也日渐突出。近年来,从伏邪理论探讨相关问题的研究思路逐渐清晰,应用中医药防治PCI术后危险因素取得了一定的研究进展。结合无复流诊疗现状,从伏邪和治未病角度出发,提出预防伏邪产生及祛除伏邪是防治PCI术后无复流、慢血流等危险因素的重要手段,为中西医结合治疗拓宽了思路。Percutaneous coronary intervention（PCI） has become the main treatment in revascularization of coronary heart disease today, but at the same time,it can increase the risk of PCI no - reflow. Recently, the research on ideas of Fuxie theory and issues related to no - reflow has gradually clear, the application of Chinese medicine in preventing and treating the risk factors of PCI has made some progress. This article discoursed from the point of view of Fuxie theory and preventive treatment of disease, providing reference to combat PCI postopertive no - reflow treatment using the combination of Chinese and Western medicine methods.

关 键 词：伏邪 治未病 PCI术后无复流 中医药 

分 类 号：R541.4[医药卫生—心血管疾病]